Citigroup’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20
Closed -$8K 6627
2021
Q1
$8K Sell
20
-37
-65% -$16K ﹤0.01% 5790
2020
Q4
$23K Buy
57
+42
+280% +$18.2K ﹤0.01% 6577
2020
Q3
$6K Sell
15
-8
-35% -$3.63K ﹤0.01% 6966
2020
Q2
$12K Buy
23
+14
+156% +$6.87K ﹤0.01% 6980
2020
Q1
$4K Buy
+9
New +$6.14K ﹤0.01% 7345
2016
Q1
Hold
0
7940
2015
Q4
Hold
0
8027
2015
Q3
Hold
0
7940

Other funds holding CFRX

Citigroup's CFRX Position: Q2 2021 in Review

Citigroup sold out of ContraFect Corporation (CFRX) in Q2 2021, closing a stake of 20 shares — an estimated $8K sold.

Citigroup first reported a position in CFRX in Q1 2020 and held it in 5 quarters. The position peaked at $23K in Q4 2020. 66 funds tracked by Wall St. Rank hold CFRX as of Q2 2021.

  • Citigroup reported no remaining ContraFect Corporation position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 20 ContraFect Corporation shares in Q2 2021, an estimated $8K.
  • Citigroup first reported a position in ContraFect Corporation in Q1 2020 and held it in 5 quarters.
  • Citigroup's ContraFect Corporation position peaked at $23K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.